ArticleInternational journal of endocrinology2025
Mendelian Randomization Analyses Reveal the Causal Effect of Cathepsin Z on the Risk of Different Subtypes of Thyroid Cancer.
Article in International journal of endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Earlier research studies employing observational methods have suggested a possible relationship between the activity of cathepsin Z and thyroid cancer (TC). However, the causal relationship linking the cathepsin Z to TC has yet to be fully established, especially for different subtypes of TC. Methods: The study employed accessible genomewide association study (GWAS) datasets to conduct bidirectional Mendelian randomization (MR) analyses. The primary approach for conducting MR analysis was the application of inverse variance weighting (IVW). Results: The MR analysis indicated that elevated cathepsin Z levels are positively linked to an elevated risk of papillary TC (PTC) development. In contrast, reverse MR indicated that PTC cannot contribute to increasing cathepsin Z levels. Conclusion: Our MR analysis suggests a causal role of cathepsin Z in the development of PTC, offering valuable insights for future mechanistic studies and potential clinical applications targeting cathepsin-mediated pathways in cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.